Analytical Data
-
Gene name
BLOT5
- Application
-
Alternative Names
Allergen: Blo t 5
-
Species
Blomia tropicalis
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O96870
-
Expression Region
1-134aa
-
Molecular Weight
31.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BLOT5 is a recombinant protein that has garnered significant interest in the field of immunology and biotechnology due to its potential applications in vaccine development and therapeutic interventions. As a key player in the immune response, BLOT5 is derived from the protein sequences found in certain pathogens, and its study aims to elucidate the mechanisms of immune recognition and activation. Understanding the structure and function of BLOT5 can lead to insights into how the immune system recognizes and responds to infections, which is critical for designing effective vaccines. Research has shown that BLOT5 can enhance the immunogenicity of vaccine candidates, making it a promising candidate for the development of next-generation vaccines against various infectious diseases. Furthermore, exploring the recombinant expression of BLOT5 allows for the production of this protein in controlled laboratory settings, facilitating studies related to its stability, efficacy, and potential applications in immunotherapeutics. The research surrounding BLOT5 not only contributes to the fundamental understanding of immune responses but also has the potential to lead to breakthroughs in the prevention and treatment of diseases that pose significant public health challenges. Overall, the ongoing investigation into BLOT5 represents a critical intersection of molecular biology, immunology, and biotechnology.
